These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 38515385

  • 1. Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice.
    Savarese G, Lindberg F, Christodorescu RM, Ferrini M, Kumler T, Toutoutzas K, Dattilo G, Bayes-Genis A, Moura B, Amir O, Petrie MC, Seferovic P, Chioncel O, Metra M, Coats AJS, Rosano GMC.
    Eur J Heart Fail; 2024 Jun; 26(6):1408-1418. PubMed ID: 38515385
    [Abstract] [Full Text] [Related]

  • 2. Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy.
    Malgie J, Clephas PRD, Brunner-La Rocca HP, de Boer RA, Brugts JJ.
    Heart Fail Rev; 2023 Sep; 28(5):1221-1234. PubMed ID: 37311917
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study.
    Quiroga B, Ortiz A, Núñez S, Kislikova M, González Sanchidrián S, Broseta JJ, Albines ZS, Escamilla Cabrera B, Rivero Viera Y, Rodriguez Santarelli D, Salanova Villanueva L, Lopez Rodriguez F, Cancho Castellano B, Ibáñez Cerezon M, Gutierrez Rivas CP, Aresté N, Campos Gutiérrez B, Ródenas Gálvez A, Glucksmann Pizá MC, Balda Manzanos S, Soldevila A, Rodríguez Gayo L, Moral Berrio E, Ortega Diaz M, Beltrán Catalán S, Puente García A, Ángel Rojas M, Sosa Barrios RH, Santana Zapatero H, Rangel Hidalgo G, Martinez Canet AM, Díez J, Cardiorenal Medicine Group (CaReSEN) of the Spanish Society of Nephrology.
    Cardiorenal Med; 2024 Sep; 14(1):202-214. PubMed ID: 38513622
    [Abstract] [Full Text] [Related]

  • 4. Eligibility and Projected Benefits of Rapid Initiation of Quadruple Therapy for Newly Diagnosed Heart Failure.
    Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW, Alhanti B, Van Spall HGC, Allen LA, Fonarow GC.
    JACC Heart Fail; 2024 Aug; 12(8):1365-1377. PubMed ID: 38597866
    [Abstract] [Full Text] [Related]

  • 5. [A practical approach to guideline-directed pharmacological treatment for heart failure with reduced ejection fraction].
    Soltani S, Böhm M, Frey N, Eden M, Abdin A, Bauersachs J.
    Dtsch Med Wochenschr; 2022 Jul; 147(14):931-938. PubMed ID: 35868319
    [Abstract] [Full Text] [Related]

  • 6. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, Wander GS, Yap JJ, MacDonald MR, Xu CF, Chia YM, Shimizu W, ASIAN-HF investigators, Richards AM, Voors A, Lam CS.
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [Abstract] [Full Text] [Related]

  • 7. Translating the 2021 ESC heart failure guideline recommendations in daily practice: Results from a heart failure survey. A scientific statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC.
    Christodorescu R, Geavlete O, Ferrini M, Kümler T, Toutoutzas K, Bayes-Genis A, Seferovic P, Metra M, Chioncel O, Rosano GMC, Savarese G.
    Eur J Heart Fail; 2024 Sep 24. PubMed ID: 39318024
    [Abstract] [Full Text] [Related]

  • 8. Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020.
    Karlström P, Pivodic A, Dahlström U, Fu M.
    Clin Res Cardiol; 2024 Sep 24; 113(9):1355-1368. PubMed ID: 39186181
    [Abstract] [Full Text] [Related]

  • 9. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry.
    Tomasoni D, Pagnesi M, Colombo G, Chiarito M, Stolfo D, Baldetti L, Lombardi CM, Adamo M, Maggi G, Inciardi RM, Loiacono F, Maccallini M, Villaschi A, Gasparini G, Montella M, Contessi S, Cocianni D, Perotto M, Barone G, Merlo M, Cappelletti AM, Rosano G, Sinagra G, Pini D, Savarese G, Metra M.
    Eur J Heart Fail; 2024 Feb 24; 26(2):327-337. PubMed ID: 37933210
    [Abstract] [Full Text] [Related]

  • 10. Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry.
    Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, Hill CL, McCague K, Mi X, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Fonarow GC.
    J Am Coll Cardiol; 2018 Jul 24; 72(4):351-366. PubMed ID: 30025570
    [Abstract] [Full Text] [Related]

  • 11. Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology.
    Mullens W, Martens P, Testani JM, Tang WHW, Skouri H, Verbrugge FH, Fudim M, Iacoviello M, Franke J, Flammer AJ, Palazzuoli A, Barragan PM, Thum T, Marcos MC, Miró Ò, Rossignol P, Metra M, Lassus J, Orso F, Jankowska EA, Chioncel O, Milicic D, Hill L, Seferovic P, Rosano G, Coats A, Damman K.
    Eur J Heart Fail; 2022 Apr 24; 24(4):603-619. PubMed ID: 35239201
    [Abstract] [Full Text] [Related]

  • 12. Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study.
    Driscoll A, Dinh D, Wong J, Hopper I, Mariani J, Zimmet H, Brennan A, Lefkovits J, Carruthers H, Reid CM.
    Heart Lung Circ; 2020 Dec 24; 29(12):1782-1789. PubMed ID: 32646638
    [Abstract] [Full Text] [Related]

  • 13. The Optimization of Guideline-Directed Medical Therapy during Hospitalization among Patients with Heart Failure with Reduced Ejection Fraction in Daily Clinical Practice.
    Bánfi-Bacsárdi F, Muk B, Pilecky D, Duray GZ, Kiss RG, Nyolczas N.
    Cardiology; 2023 Dec 24; 148(1):27-37. PubMed ID: 36470212
    [Abstract] [Full Text] [Related]

  • 14. Adherence to Treatment Guidelines in Ambulatory Heart Failure Patients with Reduced Ejection Fraction in a Latin-American Country: Observational Study of the Colombian Heart Failure Registry (RECOLFACA).
    Rivera-Toquica A, Echeverría LE, Arias-Barrera CA, Mendoza-Beltrán F, Hoyos-Ballesteros DH, Plata-Mosquera CA, Ortega-Madariaga JC, Carvajal-Estupiñán JF, Quintero-Yepes V, Zárate-Correa LC, García-Peña ÁA, Velásquez-López N, Anchique CV, Saldarriaga CI, Gómez-Mesa JE.
    Cardiology; 2024 Dec 24; 149(3):228-236. PubMed ID: 38359813
    [Abstract] [Full Text] [Related]

  • 15. Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.
    Vaduganathan M, Claggett BL, Jhund PS, Cunningham JW, Pedro Ferreira J, Zannad F, Packer M, Fonarow GC, McMurray JJV, Solomon SD.
    Lancet; 2020 Jul 11; 396(10244):121-128. PubMed ID: 32446323
    [Abstract] [Full Text] [Related]

  • 16. Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction.
    Schupp T, Bertsch T, Reinhardt M, Abel N, Schmitt A, Lau F, Abumayyaleh M, Akin M, Weiß C, Weidner K, Behnes M, Akin I.
    Eur J Prev Cardiol; 2024 Aug 22; 31(11):1347-1360. PubMed ID: 38513366
    [Abstract] [Full Text] [Related]

  • 17. Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.
    Vaduganathan M, Fonarow GC, Greene SJ, DeVore AD, Kavati A, Sikirica S, Albert NM, Duffy CI, Hill CL, Patterson JH, Spertus JA, Thomas LE, Williams FB, Hernandez AF, Butler J.
    JACC Heart Fail; 2020 Jun 22; 8(6):469-480. PubMed ID: 32387066
    [Abstract] [Full Text] [Related]

  • 18. Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States.
    Yan BW, Spahillari A, Pandya A.
    Circ Cardiovasc Qual Outcomes; 2023 Jun 22; 16(6):e009793. PubMed ID: 37278232
    [Abstract] [Full Text] [Related]

  • 19. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK, Sharma K, Mittal S, Monteiro R, Libbus I, Ardell JL, Gregory DD, KenKnight BH, Amurthur B, DiCarlo LA, Anand IS.
    ESC Heart Fail; 2019 Oct 22; 6(5):1052-1056. PubMed ID: 31339232
    [Abstract] [Full Text] [Related]

  • 20. Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: First data from the TITRATE-HF study.
    Malgie J, Wilde MI, Clephas PRD, Emans ME, Koudstaal S, Schaap J, Mosterd A, van Ramshorst J, Wardeh AJ, van Wijk S, van den Heuvel M, Wierda E, Borleffs CJW, Saraber C, Beeres SLMA, van Kimmenade R, Jansen Klomp W, Denham R, da Fonseca CA, Klip IT, Manintveld OC, van der Boon RMA, van Ofwegen CEE, Yilmaz A, Pisters R, Linssen GCM, Faber N, van Heerebeek L, van de Swaluw JEC, Bouhuijzen LJ, Post MC, Kuijper AFM, Wu KW, van Beek EA, Hesselink T, Kleijn L, Kurvers MJM, Tio RA, Langerveld J, van Dalen BM, van Eck JWM, Handoko ML, Hermans WRM, Koornstra-Wortel HJJ, Szymanski MK, Rooker D, Tandjung K, Eijsbouts SCM, Asselbergs FW, van der Meer P, Brunner-La Rocca HP, de Boer RA, Brugts JJ.
    Eur J Heart Fail; 2024 Jul 22; 26(7):1549-1560. PubMed ID: 38734980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.